Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Palestinian leader Abbas says elections only after Gaza war ends - 2Support Your Investment funds with These Individual accounting Thoughts
- 3Iran-backed Iraqi militias attack Kurdistan over 450 times since beginning of war
- 4Israeli Chief of Staff declares new border with Gaza Strip
- 5Former IRGC child executioner tells ‘Post’ how he became devout Christian dissident
- Watch Chinese astronauts enjoy '1st ever space BBQ' from Tiangong's brand-new oven (video)
- Untamed life Safe-havens All over the Planet Offering Remarkable Creature Experiences
- The Solution to Flexibility: Developing Internal Fortitude Notwithstanding Misfortune
- Germany and trade unions kick off tough public-sector wage talks
- Instructions to Clean and Really focus on Your Lab Precious stone
- Flu cases are rising with a strain that makes older people sicker
- 37 Things Just Individuals Experiencing childhood during the 80s Will Comprehend
- 2 new malaria treatments announced as drug resistance grows
- First Houthi launch toward Israel since war began triggers alerts across the Negev
